Opportunity Information: Apply for PA 08 015
Apply for PA 08 015
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Angiogenesis in the Nervous System in Health and Disease (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.866 Aging Research 93.867 Vision Research.
- This funding opportunity was created on Dec 5, 2008 and posted on Oct 23, 2007.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) County governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education City or township governments For profit organizations other than small businesses Private institutions of higher education Small businesses Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments.
- Foreign institutions are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity "Angiogenesis in the Nervous System in Health and Disease (R01)" (Funding Opportunity Number PA-08-015) is a Program Announcement that supports research focused on how blood vessels form, grow, and remodel within the nervous system under both normal conditions and disease states. It is jointly issued by several NIH institutes with overlapping interests in neurovascular biology and disease: the National Institute of Neurological Disorders and Stroke (NINDS), the National Eye Institute (NEI), the National Institute on Aging (NIA), the National Cancer Institute (NCI), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The core intent is to bring in investigator-initiated R01 applications that deepen the field's understanding of nervous system angiogenesis, including basic mechanisms, developmental patterning, and the causes of disorders where vascular growth or maintenance in neural tissues goes wrong.
Scientifically, the announcement emphasizes three broad, connected themes. First, it encourages work on the mechanisms that control angiogenic responses to both physiological signals (for example, normal development, tissue activity, metabolic demand, or repair processes) and pathological stimuli (such as injury, ischemia, neurodegeneration, inflammation, tumor-related signals, or other disease-associated stressors). This includes the signaling pathways and cellular interactions that govern when and where new vessels sprout, how they stabilize, and how they interact with surrounding neural and glial cells. Second, the FOA explicitly calls for studies of how nervous system vasculature develops and becomes patterned, meaning how vascular networks are organized in the brain, spinal cord, retina, and related tissues, and how those networks become properly structured to meet the specialized needs of neural environments. Third, it invites research into the etiology of disorders that affect vascular development and/or ongoing angiogenesis in nervous system tissues, recognizing that disrupted vascular growth, vessel instability, or abnormal remodeling can contribute directly to disease onset, progression, or functional decline.
From a funding mechanism standpoint, this opportunity uses the NIH Research Project Grant (R01) mechanism, which is generally intended for more mature, hypothesis-driven projects with a well-developed research plan and sufficient preliminary rationale. The FOA is paired with a companion announcement of the same scientific scope that uses the R21 Exploratory/Developmental mechanism (PA-08-016), intended for earlier-stage, higher-risk, or more proof-of-concept work; however, the notice highlights that NIDDK does not participate in the companion R21 FOA even though it participates in this R01 version. In practice, that detail matters for applicants trying to align institute priorities and submission strategy, especially if they are considering whether an exploratory R21 approach is appropriate for their aims or whether they should pursue an R01 directly.
In terms of who can apply, eligibility is broad and includes many types of domestic organizations such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, with some distinctions), for-profit organizations (including small businesses and other for-profits), and multiple levels of government entities (state, county, city/township, special districts), as well as independent school districts and public housing authorities/Indian housing authorities. Importantly, foreign institutions are eligible to apply, which signals that the NIH is open to supporting high-quality neurovascular angiogenesis research regardless of geography, provided the application meets NIH standards and aligns with the participating institutes' missions.
The announcement does not specify a fixed pot of money or a guaranteed number of awards. Instead, it states that awards depend on the availability of funds and on receiving a sufficient number of meritorious applications. That is typical for many NIH program announcements and means that competitiveness will be driven by scientific quality, significance, innovation, approach, investigator capability, and alignment with institute priorities, rather than by a predetermined set-aside budget. The opportunity is listed under multiple CFDA numbers reflecting the cross-cutting relevance to cancer research, diabetes/digestive/kidney extramural research, neuroscience and neurological disorders, aging research, and vision research, reinforcing that nervous system angiogenesis is a shared biological and clinical concern across many disease areas.
Administratively, the FOA was posted on October 23, 2007, with an archive date of February 7, 2011, and it used multiple receipt dates rather than a single deadline, meaning applications could be submitted on standard NIH cycles during the active period. There is no cost sharing or matching requirement. The full announcement was hosted on the NIH grants site (grants.nih.gov), and the provided contact route for access or linking issues is the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV), which is primarily for technical access problems rather than scientific guidance. Overall, the opportunity is designed to grow a portfolio of R01-level projects that explain how neurovascular networks are built and regulated, why they fail in certain diseases, and how those insights might ultimately inform prevention, diagnosis, or treatment strategies across neurological, ocular, aging-related, metabolic, and cancer-relevant conditions.
Frequently Asked Questions (FAQs)
What is the funding opportunity number and title?
The opportunity is NIH PA-08-015, titled "Angiogenesis in the Nervous System in Health and Disease (R01)."
What type of NIH announcement is this?
This is a Program Announcement that solicits investigator-initiated applications under the R01 mechanism.
What is the main purpose of this FOA?
The FOA supports research on how blood vessels form, grow, and remodel within the nervous system under normal conditions and in disease states, with the goal of deepening understanding of nervous system angiogenesis, including mechanisms, developmental patterning, and causes of disorders involving abnormal vascular growth or maintenance in neural tissues.
Which NIH institutes jointly issue or participate in this FOA?
The FOA is jointly issued by: the National Institute of Neurological Disorders and Stroke (NINDS), the National Eye Institute (NEI), the National Institute on Aging (NIA), the National Cancer Institute (NCI), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
What research topics are emphasized?
The announcement emphasizes three connected themes: (1) mechanisms controlling angiogenic responses to physiological and pathological stimuli, including signaling pathways and cellular interactions involved in sprouting, stabilization, and interactions with neural and glial cells; (2) development and patterning of nervous system vasculature, including organization of vascular networks in the brain, spinal cord, retina, and related tissues; and (3) the etiology of disorders that affect vascular development and/or ongoing angiogenesis in nervous system tissues, including disease contributions from disrupted growth, vessel instability, or abnormal remodeling.
What kinds of stimuli or conditions does the FOA highlight for angiogenic responses?
The FOA highlights both physiological signals (such as normal development, tissue activity, metabolic demand, and repair processes) and pathological stimuli (such as injury, ischemia, neurodegeneration, inflammation, tumor-related signals, and other disease-associated stressors).
Which nervous system tissues or regions are explicitly mentioned?
The FOA explicitly mentions vascular networks in the brain, spinal cord, retina, and related tissues.
What grant mechanism is used?
This opportunity uses the NIH Research Project Grant (R01) mechanism.
How does this R01 FOA relate to the companion R21 announcement?
The FOA is paired with a companion announcement of the same scientific scope using the R21 Exploratory/Developmental mechanism (PA-08-016), which is described as intended for earlier-stage, higher-risk, or proof-of-concept work.
Does every participating institute also participate in the companion R21 FOA?
No. The information provided notes that NIDDK participates in this R01 version but does not participate in the companion R21 FOA (PA-08-016).
Who is eligible to apply?
Eligibility is broad and includes domestic organizations such as public and private institutions of higher education; nonprofits (including those with and without 501(c)(3) status, with some distinctions); for-profit organizations (including small businesses and other for-profits); and multiple levels of government entities (state, county, city/township, special districts), as well as independent school districts and public housing authorities/Indian housing authorities.
Are foreign institutions eligible to apply?
Yes. Foreign institutions are eligible to apply under this opportunity.
Is there a set amount of funding or a guaranteed number of awards?
No. The FOA does not specify a fixed pot of money or a guaranteed number of awards. It states that awards depend on the availability of funds and on receiving a sufficient number of meritorious applications.
What determines whether an application is competitive for funding under this announcement?
Based on the description provided, competitiveness is driven by the merit of the applications and alignment with participating institute priorities, rather than a predetermined set-aside budget.
Are cost sharing or matching funds required?
No. The announcement states there is no cost sharing or matching requirement.
What CFDA areas does this FOA span?
The FOA is listed under multiple CFDA numbers reflecting relevance to cancer research, diabetes/digestive/kidney extramural research, neuroscience and neurological disorders, aging research, and vision research.
When was this FOA posted, and when was it archived?
The FOA was posted on October 23, 2007, and has an archive date of February 7, 2011.
Did this FOA use a single deadline or multiple receipt dates?
It used multiple receipt dates rather than a single deadline, meaning applications could be submitted on standard NIH cycles during the active period.
Where was the full announcement hosted?
The full announcement was hosted on the NIH grants site (grants.nih.gov).
Who should be contacted for technical access or linking issues related to the announcement?
The provided contact route for access or linking issues is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
Is the listed contact intended for scientific or programmatic questions?
No. The information provided indicates the webmaster contact is primarily for technical access problems rather than scientific guidance.
What overall impact is the NIH seeking through this FOA?
The opportunity is designed to grow a portfolio of R01-level projects that explain how neurovascular networks are built and regulated, why they fail in certain diseases, and how those insights might ultimately inform prevention, diagnosis, or treatment strategies across neurological, ocular, aging-related, metabolic, and cancer-relevant conditions.
Browse more opportunities from the same category: Education Health
Next opportunity: Angiogenesis in the Nervous System in Health and Disease (R21)
Previous opportunity: ELSI Small Research Grant Program (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 08 015
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 08 015) also looked into and applied for these:
| Funding Opportunity |
|---|
| Angiogenesis in the Nervous System in Health and Disease (R21) Apply for PA 08 016 Funding Number: PA 08 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Quick Trials for Novel Cancer Therapies and Prevention Exploratory Grants (R21) Apply for PAR 08 025 Funding Number: PAR 08 025 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Research on Co Morbid Mental and Other Physical Disorders (R01) Apply for PA 08 029 Funding Number: PA 08 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exfoliated Cells, Bioactive Food Components, and Cancer (R01) Apply for PA 08 030 Funding Number: PA 08 030 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exfoliated Cells, Bioactive Food Components, and Cancer (R21) Apply for PA 08 031 Funding Number: PA 08 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Molecular Approaches to Diet and Pancreatic Cancer Prevention (R01) Apply for PA 08 032 Funding Number: PA 08 032 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Thyroid in Aging (R01) Apply for PA 08 037 Funding Number: PA 08 037 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Thyroid in Aging (R21) Apply for PA 08 038 Funding Number: PA 08 038 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Thyroid in Aging (R03) Apply for PA 08 039 Funding Number: PA 08 039 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Outcomes, Cost Effectiveness and the Decision Making Process to Use Complementary and Alternative Medicine (R01) Apply for PAR 08 045 Funding Number: PAR 08 045 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding and Preventing Brain Tumor Dispersal (R01) Apply for PAS 08 048 Funding Number: PAS 08 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding and Preventing Brain Tumor Dispersal (R21) Apply for PAS 08 049 Funding Number: PAS 08 049 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Long Acting, Sustainable Therapies for Opiate Addiction (R01) Apply for PAS 08 061 Funding Number: PAS 08 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Alzheimer s Disease Pilot Clinical Trials (R01) Apply for PAR 08 062 Funding Number: PAR 08 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Decision Making in Cancer Single Event Decisions (R01) Apply for PA 08 063 Funding Number: PA 08 063 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Decision Making in Cancer Single Event Decisions (R21) Apply for PA 08 064 Funding Number: PA 08 064 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on the Economics of Diet, Activity and Energy Balance (R21) Apply for PA 08 077 Funding Number: PA 08 077 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NLM Express Research Grants in Biomedical Informatics (R01) Apply for PAR 08 080 Funding Number: PAR 08 080 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) Apply for PA 08 084 Funding Number: PA 08 084 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) Apply for PA 08 085 Funding Number: PA 08 085 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 015", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
